Global Cord Blood Corporation Stock Börse Stuttgart
Equities
6CB
KYG393421030
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.96 EUR | +1.02% | +4.21% | +38.46% |
2023 | Global Cord Blood Corporation Announces Board Appointments | CI |
2023 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
Sales 2021 | 1.16B 160M 147M 219M | Sales 2022 | 1.24B 172M 158M 234M | Capitalization | 2.97B 409M 377M 559M |
---|---|---|---|---|---|
Net income 2021 | 508M 70.08M 64.58M 95.74M | Net income 2022 | 501M 69.12M 63.69M 94.42M | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 838M 772M 1.14B | Net cash position 2022 | 6.66B 919M 847M 1.26B | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
1 week | +4.21% | ||
1 month | +2.06% | ||
3 months | -9.59% | ||
6 months | +2.06% | ||
Current year | +38.46% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 08-12-31 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 04-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 08-12-31 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Director/Board Member | 56 | 08-12-31 |
1st Jan change | Capi. | |
---|---|---|
+17.73% | 83.46B | |
-32.08% | 67.33B | |
-1.97% | 25.66B | |
+2.96% | 17.91B | |
-13.68% | 16.54B | |
+0.75% | 15.43B | |
+74.92% | 13.46B | |
+73.16% | 12.78B | |
-2.02% | 12.33B |
- Stock Market
- Equities
- CORBF Stock
- 6CB Stock